AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elekta

Legal Proceedings Report Aug 13, 2013

2906_rns_2013-08-13_e2ca2a68-6d88-4a91-b2e9-6326b5149250.pdf

Legal Proceedings Report

Open in Viewer

Opens in native device viewer

Lawsuit with Varian Medical Systems resolved

Stockholm, August 13, 2013 – Elekta informs that the lawsuit, announced in August 2012, with Varian Medical Systems has been resolved by mutual agreement by the parties.

#

For further information, please contact: Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, e-mail: [email protected] Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on August 13, 2013.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.